The Traderszone Network

Financial Highlights for the Fiscal Third Quarter Ending August 31, 2017

NEW YORK, Oct. 16, 2017 (GLOBE NEWSWIRE) — Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology company developing innovative medicines and imaging analytical tools for targeting and treating cancer, announced today that data from several of the Company’s development programs will be presented in oral sessions at the 30th Annual Congress of the European Association of Nuclear Medicine (EANM), which is being held in Vienna, Austria from October 21 through 25, 2017.

NEW YORK, Oct. 16, 2017 (GLOBE NEWSWIRE) — AmTrust Financial Services, Inc. (Nasdaq:AFSI) (“AmTrust”) announced today that it plans to release its third quarter 2017 results after the market closes on Wednesday, November 8, 2017. At 5:30 PM ET that same day, Chairman and Chief Executive Officer Barry Zyskind, and EVP and Chief Financial Officer Adam Karkowsky, will review results and discuss business conditions and business outlook via a conference call and webcast that may be accessed as follows:

PLANO, Texas, Oct. 16, 2017 (GLOBE NEWSWIRE) — Denbury Resources Inc. (NYSE:DNR) (“Denbury” or the “Company”) will host a conference call to review and discuss third quarter 2017 financial and operating results on Tuesday, November 7, 2017 at 10:00 A.M. (Central).  The Company plans to issue its financial and operating results prior to the market opening on the same day.  Individuals who would like to participate should dial the applicable dial-in number listed below ten minutes before the scheduled start time.

CAMBRIDGE, Mass., Oct. 16, 2017 (GLOBE NEWSWIRE) — CarGurus, Inc. (NASDAQ:CARG), a global, online automotive marketplace connecting buyers and sellers of new and used cars, today announced the closing of its initial public offering of 10,810,000 shares of Class A common stock, including the full exercise by the underwriters of their option to purchase 1,410,000 additional shares of Class A common stock, at a public offering price of $16.00 per share, before underwriting discounts.

read more

CINCINNATI, Oct. 16, 2017 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ:VIVO), a leading diagnostic and life science component company, expects to release its fiscal 2018 Revenue and Earnings Guidance before the NASDAQ market opens on Thursday, October 19.

read more

WINNIPEG, Manitoba, Oct.

read more